King's College London

Research portal

Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia

Research output: Contribution to journalArticle

Standard

Beyond cure : patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. / Madden, Annie; Hopwood, Max; Neale, Joanne; Treloar, Carla.

In: Harm Reduction Journal, Vol. 15, No. 42, 15.08.2018, p. 42.

Research output: Contribution to journalArticle

Harvard

Madden, A, Hopwood, M, Neale, J & Treloar, C 2018, 'Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia', Harm Reduction Journal, vol. 15, no. 42, pp. 42. https://doi.org/10.1186/s12954-018-0248-4

APA

Madden, A., Hopwood, M., Neale, J., & Treloar, C. (2018). Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduction Journal, 15(42), 42. https://doi.org/10.1186/s12954-018-0248-4

Vancouver

Madden A, Hopwood M, Neale J, Treloar C. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduction Journal. 2018 Aug 15;15(42):42. https://doi.org/10.1186/s12954-018-0248-4

Author

Madden, Annie ; Hopwood, Max ; Neale, Joanne ; Treloar, Carla. / Beyond cure : patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. In: Harm Reduction Journal. 2018 ; Vol. 15, No. 42. pp. 42.

Bibtex Download

@article{40a02727f7b6434e89fdc093464b93b9,
title = "Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia",
abstract = "BackgroundRecent advances in the treatment of hepatitis C virus (HCV) infection provide the possibility of eliminating HCV as a public health threat. This focus on HCV elimination through treatment, however, is also driving a concomitant focus on ‘achieving cure’ as the primary outcome of treatment. The aim of this paper is to explore what people who inject drugs consider to be important in relation to outcomes of HCV treatment, and whether there are outcomes ‘beyond cure’ that might be important to understand as part of improving engagement in treatment.MethodsA peer researcher with experience of both HCV treatment and injecting drug use conducted interviews with 24 people in the following groups in Melbourne, Australia: (1) people who had refused or deferred HCV treatment; (2) people who were actively thinking about, planning and/or about to commence HCV treatment; (3) people currently undertaking HCV treatment and (4) people who had recently completed HCV treatment.ResultsThe findings show that people who inject drugs are seeking outcomes ‘beyond cure’ including improved physical and mental health, positive changes in identity and social relationships and managing future health and risk. Participants indicated that these other outcomes had not been addressed within their experience of HCV treatment.ConclusionWhile cure is an obvious outcome of HCV treatment, patients are seeking change in other areas of their lives. This study also provides valuable insights for the development of patient-reported measures in this context, which would be an important step towards more patient-centred approaches to HCV treatment.",
author = "Annie Madden and Max Hopwood and Joanne Neale and Carla Treloar",
year = "2018",
month = "8",
day = "15",
doi = "10.1186/s12954-018-0248-4",
language = "English",
volume = "15",
pages = "42",
journal = "Harm Reduction Journal",
issn = "1477-7517",
publisher = "BioMed Central",
number = "42",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Beyond cure

T2 - patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia

AU - Madden, Annie

AU - Hopwood, Max

AU - Neale, Joanne

AU - Treloar, Carla

PY - 2018/8/15

Y1 - 2018/8/15

N2 - BackgroundRecent advances in the treatment of hepatitis C virus (HCV) infection provide the possibility of eliminating HCV as a public health threat. This focus on HCV elimination through treatment, however, is also driving a concomitant focus on ‘achieving cure’ as the primary outcome of treatment. The aim of this paper is to explore what people who inject drugs consider to be important in relation to outcomes of HCV treatment, and whether there are outcomes ‘beyond cure’ that might be important to understand as part of improving engagement in treatment.MethodsA peer researcher with experience of both HCV treatment and injecting drug use conducted interviews with 24 people in the following groups in Melbourne, Australia: (1) people who had refused or deferred HCV treatment; (2) people who were actively thinking about, planning and/or about to commence HCV treatment; (3) people currently undertaking HCV treatment and (4) people who had recently completed HCV treatment.ResultsThe findings show that people who inject drugs are seeking outcomes ‘beyond cure’ including improved physical and mental health, positive changes in identity and social relationships and managing future health and risk. Participants indicated that these other outcomes had not been addressed within their experience of HCV treatment.ConclusionWhile cure is an obvious outcome of HCV treatment, patients are seeking change in other areas of their lives. This study also provides valuable insights for the development of patient-reported measures in this context, which would be an important step towards more patient-centred approaches to HCV treatment.

AB - BackgroundRecent advances in the treatment of hepatitis C virus (HCV) infection provide the possibility of eliminating HCV as a public health threat. This focus on HCV elimination through treatment, however, is also driving a concomitant focus on ‘achieving cure’ as the primary outcome of treatment. The aim of this paper is to explore what people who inject drugs consider to be important in relation to outcomes of HCV treatment, and whether there are outcomes ‘beyond cure’ that might be important to understand as part of improving engagement in treatment.MethodsA peer researcher with experience of both HCV treatment and injecting drug use conducted interviews with 24 people in the following groups in Melbourne, Australia: (1) people who had refused or deferred HCV treatment; (2) people who were actively thinking about, planning and/or about to commence HCV treatment; (3) people currently undertaking HCV treatment and (4) people who had recently completed HCV treatment.ResultsThe findings show that people who inject drugs are seeking outcomes ‘beyond cure’ including improved physical and mental health, positive changes in identity and social relationships and managing future health and risk. Participants indicated that these other outcomes had not been addressed within their experience of HCV treatment.ConclusionWhile cure is an obvious outcome of HCV treatment, patients are seeking change in other areas of their lives. This study also provides valuable insights for the development of patient-reported measures in this context, which would be an important step towards more patient-centred approaches to HCV treatment.

U2 - 10.1186/s12954-018-0248-4

DO - 10.1186/s12954-018-0248-4

M3 - Article

VL - 15

SP - 42

JO - Harm Reduction Journal

JF - Harm Reduction Journal

SN - 1477-7517

IS - 42

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454